Recombinant 9-valent human papillomavirus vaccine (Rec-bio)

重组九价HPV疫苗（瑞科生物）

Report date: 2025/12/11 10:02:59

Base Information

Drug NameRecombinant 9-valent human papillomavirus vaccine (Rec-bio)

Drug Alias NameREC-604b

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsPapillomavirus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaDiscontinued

Originator CompaniesJiangsu Rec-Biotechnology Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesJiangsu Rec-Biotechnology Co Ltd

Active IndicationsN/A

Inactive IndicationsPapillomavirus Infections

Other Information

ATC CodeN/A